Cbio A/S is a clinical stage cell therapy company started in 2019 focusing on Tumor Infiltrating Lymphocyte (TIL) therapy – the most promising cell therapy for solid tumors. We have have developed a proprietary next-generation TIL manufacturing process with transformative potential. Our lead TIL therapy product, novoleucel, is now ready for clinical validation. We are located in Søborg (Copenhagen area), Denmark in a 1,000 m2 state-of-the-art facility where we develop and produce cell-based therapy products for clinical use.
View Top Employees from Cbio A/SWebsite | http://www.cbio.dk |
Employees | 11 (11 on RocketReach) |
Founded | 2019 |
Technologies | |
Industry | Biotechnology Research |
Looking for a particular Cbio A/S employee's phone or email?
Ulrik Cordes is the CEO of Cbio A/S.
11 people are employed at Cbio A/S.